These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 26544657)
1. Letter to the Editor: Comment on "Effect of Growth Hormone Treatment on Fractures and Quality of Life in Postmenopausal Osteoporosis: A 10-Year Follow-Up Study" by Kratz E., et al. Salvatori R J Clin Endocrinol Metab; 2015 Nov; 100(11):L107. PubMed ID: 26544657 [No Abstract] [Full Text] [Related]
2. Response to the Letter by Salvatori R. Krantz E; Trimpou P; Landin-Wilhelmsen K J Clin Endocrinol Metab; 2015 Nov; 100(11):L108. PubMed ID: 26544658 [No Abstract] [Full Text] [Related]
3. Bone: Antifracture efficacy of growth hormone-confirmation at long last. Holmes D Nat Rev Endocrinol; 2015 Nov; 11(11):631. PubMed ID: 26391976 [No Abstract] [Full Text] [Related]
4. Effect of Growth Hormone Treatment on Fractures and Quality of Life in Postmenopausal Osteoporosis: A 10-Year Follow-Up Study. Krantz E; Trimpou P; Landin-Wilhelmsen K J Clin Endocrinol Metab; 2015 Sep; 100(9):3251-9. PubMed ID: 26312576 [TBL] [Abstract][Full Text] [Related]
5. Calcium, vitamin D and vitamin K in the prevention of fractures due to osteoporosis. Meunier PJ Osteoporos Int; 1999; 9 Suppl 2():S48-52. PubMed ID: 10525726 [No Abstract] [Full Text] [Related]
10. [Osteoporosis therapy in general practice. Which measure should be included?]. Abendroth K MMW Fortschr Med; 2002 Oct; 144(42):62. PubMed ID: 12534001 [No Abstract] [Full Text] [Related]
11. A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D. Henriksen K; Byrjalsen I; Andersen JR; Bihlet AR; Russo LA; Alexandersen P; Valter I; Qvist P; Lau E; Riis BJ; Christiansen C; Karsdal MA; Bone; 2016 Oct; 91():122-9. PubMed ID: 27462009 [TBL] [Abstract][Full Text] [Related]
12. Strontium: new drug. Postmenopausal osteoporosis: too many unknowns. Prescrire Int; 2005 Dec; 14(80):207-11. PubMed ID: 16397977 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of depressive symptoms in postmenopausal women with low bone mineral density and/or prevalent vertebral fracture: results from the Multiple Outcomes of Raloxifene Evaluation (MORE) study. Silverman SL; Shen W; Minshall ME; Xie S; Moses KH J Rheumatol; 2007 Jan; 34(1):140-4. PubMed ID: 17216681 [TBL] [Abstract][Full Text] [Related]
15. Drugs for prevention and treatment of postmenopausal osteoporosis. Treat Guidel Med Lett; 2005 Oct; 3(38):69-74. PubMed ID: 16177651 [No Abstract] [Full Text] [Related]
16. Clinical Inquiries: Does vitamin D without calcium reduce fracture risk? Daly S; Allison C; Nashelsky J J Fam Pract; 2016 Dec; 65(12):933-934. PubMed ID: 28149982 [TBL] [Abstract][Full Text] [Related]
17. The treatment of osteoporosis. Antiresorptive therapy. Miller PD Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624 [TBL] [Abstract][Full Text] [Related]
18. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. Black DM; Greenspan SL; Ensrud KE; Palermo L; McGowan JA; Lang TF; Garnero P; Bouxsein ML; Bilezikian JP; Rosen CJ; N Engl J Med; 2003 Sep; 349(13):1207-15. PubMed ID: 14500804 [TBL] [Abstract][Full Text] [Related]
19. Calcium and vitamin D supplements for elderly patients. Feit JM J Fam Pract; 1997 Dec; 45(6):471-2. PubMed ID: 9420580 [No Abstract] [Full Text] [Related]
20. Clinical Practice. Postmenopausal Osteoporosis. Black DM; Rosen CJ N Engl J Med; 2016 Jan; 374(3):254-62. PubMed ID: 26789873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]